CompuGroup Medical SE KgaA (XTER:COP) Marketable Securities : €5 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. CompuGroup Medical SE KgaA's Marketable Securities for the quarter that ended in Mar. 2024 was €5 Mil.

CompuGroup Medical SE KgaA's annual Marketable Securities increased from Dec. 2021 (€0 Mil) to Dec. 2022 (€0 Mil) but then declined from Dec. 2022 (€0 Mil) to Dec. 2023 (€0 Mil).

CompuGroup Medical SE KgaA Marketable Securities Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Marketable Securities Chart

CompuGroup Medical SE KgaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

0.94

1.00

0.43

0.50

0.15

CompuGroup Medical SE KgaA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															3.54	6.44	3.22	0.15	5.45

CompuGroup Medical SE KgaA Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

CompuGroup Medical SE KgaA (XTER:COP) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

CompuGroup Medical SE KgaA Marketable Securities Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

CompuGroup Medical SE KgaA (XTER:COP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

CMPUY:USA COPd:UK 0MSD:UK COP:Austria

Address

Maria Trost 21, Koblenz, DEU, 56070

Website

https://www.cgm.com

CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.

Executives

Michael Rauch	Managing director of the general partner of the issuer
Emanuele Mugnani	Managing director of the general partner of the issuer
Frank Gotthardt	Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt	Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl	Managing director of the general partner of the issuer
Dr. Eckart Pech	Managing director of the general partner of the issuer
Dr. Dirk Wössner	CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen	Managing director of the general partner of the issuer